At AACR, Revolution Medicines presented more eye-catching data about its KRAS-targeting treatment, and Anthony Letai declared ...

A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the Justice Department on Tuesday, ...

Defense Secretary Pete Hegseth announced Tuesday that the U.S. military will no longer require all American troops to get the ...

A company that is changing the outlook on pancreatic cancer has more promising data for treatments near-term and for a ...

The Swiss drugmaker Roche presented the latest data for its experimental multiple sclerosis drug, setting the stage for the ...

A one-time cell therapy from Kyverna Therapeutics for stiff person syndrome, a rare disease, improved mobility and reduced ...

Tortugas Neuroscience launched Tuesday with plans to develop drugs licensed from Chinese drugmaker Jiangsu Hansoh and ...

Lawmakers seem poised to reject cuts to biomedical research and public health spending for a second straight year.

WASHINGTON — The Trump administration’s plan for providing cheap weight-loss drugs to seniors in Medicare might be falling ...

In outpatient medicine, decisions move quickly. A prescription is sent to a pharmacy. A referral goes out to a specialist. A ...

BioAge Labs said its investigational pill for cardiovascular risk prevention significantly reduced inflammation in an early ...

The Senate GOP doctors who will question RFK Jr. There are four Republican doctors on two of the Senate committees at which ...